Results 141 to 150 of about 12,748 (199)

Enzyme therapy in a structural light. [PDF]

IUCrJ
Cooper J.
europepmc   +1 more source

A 12-Step Desensitization Protocol for Calaspargase Pegol-mknl. [PDF]

J Pediatr Pharmacol Ther
Nguyen MHN, Memken A, Sriaroon P, Hajirawala M, Mayer JLR.   +4 more
europepmc   +1 more source

PecS is a global regulator of the symptomatic phase in the phytopathogenic bacterium Erwinia chrysanthemi 3937. [PDF]

J Bacteriol, 2008
Hommais F, Oger-Desfeux C, Van Gijsegem F, Castang S, Ligori S, Expert D, Nasser W, Reverchon S.   +7 more
europepmc   +1 more source

Aphid-killing bacteria: diversity, origin, mechanisms and biocontrol potential. [PDF]

Front Microbiol
Berings L, Rojas-Preciado N, Poppelsdorf W, Van Hee S, Jacquemyn H, Lievens B.   +5 more
europepmc   +1 more source

Measurement of subvisible particulates in lyophilised Erwinia chrysanthemi L-asparaginase and relationship with clinical experience. [PDF]

AAPS J, 2014
Gervais D, Corn T, Downer A, Smith S, Jennings A.   +4 more
europepmc   +1 more source

Harpin mediates cell aggregation in Erwinia chrysanthemi 3937. [PDF]

J Bacteriol, 2006
Yap MN, Rojas CM, Yang CH, Charkowski AO.   +3 more
europepmc   +1 more source

American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults. [PDF]

Blood Adv
DuVall AS, McNeer J, Cheung MC, Adrianzen-Herrera DA, Advani A, Aljurf M, Audino A, Benitez L, Deeter A, Dworkin E, Hiltbrand O, Isenalumhe L, Li L, Miller-Chism C, Mozessohn L, Ng AP, Pu JJ, Shafer D, Madueno FV, Viny A, Wadhwa A, Yang J, Zarnegar-Lumley S, Mai HJ, Kanaan G, Sereda Y, Saldanha IJ, Balk EM, Stock W, Wolfson JA.   +29 more
europepmc   +1 more source

Application and Limitations of 16S rRNA Gene Sequencing for Identifying WHO Priority Pathogenic Gram-Negative Bacilli. [PDF]

Infect Drug Resist
de Souza PA, Ramos JN, Vasconcellos L, Costa LV, Forsythe SJ, Brandão MLL.   +5 more
europepmc   +1 more source

Recombinant L-asparaginase from Stenotrophomonas maltophilia: a promising low-immunogenic anticancer agent. [PDF]

Microb Cell Fact
Abdelrazek NA, Saleh SE, Ali AE, Aboulwafa MM, Raafat MM.   +4 more
europepmc   +1 more source